AstraZeneca vaccine doses produced in India not included in Europe’s vaccine passport ahead of launch

The European Union’s much anticipated coronavirus digital certificate, which is intended to facilitate unrestricted movement across the continent for vaccinated travelers, will begin Thursday amid widespread confusion about how the rollout will go. But many vaccinated would-be travelers — particularly those from poorer countries — do not meet the program’s criteria because they received AstraZeneca shots produced by India’s Serum Institute, which has not been approved by E.U. regulators. The Serum Institute, however, is approved by the World Health Organization and is a major supplier to the Covax initiative